key: cord-0945776-fgb4lr5l
authors: Stern, Lauren; Waikar, Sushrut
title: Time To Expand Access and Utilization of Home Dialysis: Lessons From the COVID-19 Pandemic
date: 2020-06-02
journal: Mayo Clin Proc
DOI: 10.1016/j.mayocp.2020.04.038
sha: ef79d1ec5ad578636aa4f86196f4e422828f9c28
doc_id: 945776
cord_uid: fgb4lr5l

nan

COVID-19 infection in the hemodialysis population is a potential disaster looming on the horizon. On any given weekday or Saturday in the US, almost 460,000 patients with end-stage kidney disease undergo life sustaining hemodialysis treatments for three to five hours in crowded outpatient hemodialysis centers. 1 Another major concern in hemodialysis is the dependence on a small, highly trained workforce that is required for delivery of life-sustaining dialysis therapy. In the event of an outbreak afflicting dialysis staff, the workforce could be crippled. The work done every day by dialysis nurses and technicians cannot easily be replaced by most RNs and certainly not by nephrologists, who are not trained in the manual aspects of hemodialysis treatment delivery.

In response to COVID-19, several strategies are being adopted by hemodialysis units, including cohorting of patients with (suspected) COVID-19 infection, or establishment of COVID-19-only dialysis units. Outside of major cities, this is unlikely to be easily adopted across the country. What, then, could be done to prevent COVID-19 or future pandemics from endangering hundreds of thousands of hemodialysis patients and the staff? We believe that greater adoption of home dialysis technologies could avert such disasters in the future. Home dialysis therapies are uniquely poised to help some of the most vulnerable patients to be at lower risk for contracting COVID-19.

Home dialysis modalities include peritoneal dialysis and home hemodialysis, and typically require 1-2 clinic visits per month (even via telemedicine), rather than in-person visits 3 times per week. Unfortunately, these modalities are significantly underutilized within the United States for a number of reasons, including lack of training and education on the part of nephrologists, lack of education for patients, and insufficient support in the home for treatments. In the US only 7.7% of prevalent dialysis patients in 2017 were treated with peritoneal dialysis, and fewer than 2% of prevalent patients were treated with home hemodialysis. 1 Several countries have been much more effective in implementing home dialysis, with the highest utilizers being Hong Kong (82%), Jalisco region of Mexico(51%), and New Zealand (30%). 1 One of the barriers to expansion of home dialysis in the US is the lack of insurance coverage for assisted dialysis for those patients that are unable to perform their own dialysis treatments at home. This can be due to frailty or lack of family members available to assist with the procedure. A number of countries in Europe and the Middle East have systems in place for assisted peritoneal dialysis, and outcomes in these programs are similar to those with self-care. 4 One study of assisted peritoneal dialysis showed that the rate of peritonitis may actually be lower among elderly assisted patients. 4 Assisted dialysis may also be a viable alternative way to provide bedside dialysis care for patients in nursing homes and rehabilitation facilities. Having home therapies be more widely available in these settings can minimize exposure to patients Before the current pandemic, President Trump signed the Advancing American Kidney Health executive order calling for an expansion of home dialysis. This initiative on favoring home therapies has added urgency given the necessity for social distancing, which hemodialysis patients and their staff cannot do. Increased utilization of home hemodialysis or peritoneal dialysis has been made straightforward with adjustments for reimbursement by CMMS that incentivize home therapies and implementation of telehealth visits. 5 There are also a number of home remoting monitoring systems in place which provide the dialysis teams the opportunity for frequent assessment of the dialysis therapy and its impact on the patient's stability.

Unfortunately, in the midst of this crisis, rapidly transitioning in-center hemodialysis patients to home hemodialysis or peritoneal dialysis is not practical. Such a transition would require extensive training, simplified technology, and surgical access in the case of peritoneal dialysis. Furthermore, not all ESKD patients are candidates for home dialysis, either from a medical or social perspective. Home therapies in many individuals would require caregiver assistance, which is not feasible for many of our most vulnerable patients.

The delayed U.S. and global response to COVID-19 highlights systematic lack of planning and preparation, despite substantial warnings by many experts about the need for anticipating a viral pandemic. Our patients are too vulnerable and too high risk to allow in-center hemodialysis -a treatment model that originated in the 1960's -to remain the dominant treatment for the 2 million ESRD patients around the world. Now is

USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases

Influenza A (H1N1): outbreak management in a dialysis unit and clinical outcomes of infection in chronic hemodialysis patients

Assisted peritoneal dialysis as an alternative to in-center hemodialysis

Telehealth and home dialysis: A new option for patients in the United States